Primary tacrolimus immunosuppression in kidney recipients considered "higher immunological risk".
Braun
F
F
Klinik für Transplantationschirurgie, Georg-August-Universität, Göttingen, Germany. tx-plant@med.uni-gottingen.de
Lorf
T
T
Schütz
E
E
Canelo
R
R
Hanack
U
U
Döpkens
K
K
Sattler
B
B
Grupp
C
C
Ringe
B
B
D000208:Acute Disease; D000328:Adult; D000368:Aged; D002102:Cadaver; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D014019:Tissue Donors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016559:Tacrolimus